A1RE34
R$158.40
▲+0.59%
Stock
Alexandria Real Estate Equities, Inc.
Official Company Name: Alexandria Real Estate Equities, Inc.
Stock Symbol: A1RE34
Stock Market: B3 - Bovespa
Currency: Brazilian real - BRL
A1RE34 Stock Price - 1 Year Price Evolution & Moving Averages
1 Year Return
▲+24.59%
Daily closing prices, with moving averages and volumes - Brazilian real (BRL)
Moving averages:
- — EMA20
- — SMA50
- — SMA200
Alexandria Real Estate Equities, Inc. Categories
United States
languages
Real Estate
languages
REIT—Office
Real Estate
REIT—Office
Company Description
Alexandria Real Estate Equities, more simply known as Alexandria, is a real estate investment trust focusing on offices and laboratories for the tech and life science industries. It owns and operates more than 290 properties primarily in the areas of Greater Boston, San Francisco, and San Diego. Alexandria has developed a venture capital firm investing in life science companies.
A1RE34 Stock Data
| Open | R$156.64 |
| High | R$158.40 |
| Low | R$156.64 |
| Close | R$158.40 |
| Volume | 4 |
| Previous Close | R$157.47 |
| 1-Day Change | 0.93 |
| 1-Year Change | 31.26 |
| Average Daily Volume | 189 |
| 52-Week High | R$179.28 |
| 52-Week Low | R$127.14 |
Disclaimer
All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!
Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.
Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).
Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.
Please conduct your own due diligence to verify insights.